CJC-1295与DAC

产品型号：51753-57-2

功能：激素和药物，维生素和矿物质缺乏症药物，营养治疗内分泌功能的调节

认证：GMP，REACH，SGS，FDA

等级标准：医药级

类型：分析试剂

状态：固体

挥发性：不挥发物

产品名称：Cjc1295的DAC

CAS：51753-57-2

外观：白色粉末

纯度（HPLC）：98％

产品尺寸：2毫克/瓶

用法：肌肉锻炼

主要市场：全球

用法：

CJC-1295 DAC已经显示出一些惊人的结果作为激素释放激素（GHRH）模拟。 不但具有证明能增加激素分泌和它的好处的能力CJC-1295，但它已经能够这样做非常大的数额。 最近的研究的研究表明，CJC - 1295刺激GH和分泌，以及将保持一个稳定增加，而不会增加催乳激素，导致强烈的脂肪损失，并增加蛋白质的合成。

CJC-1295 DAC是一种长效激素释放激素，这会导致垂体前叶释放更多激素。 GHRH被释放在脉冲在体内，它交替生长抑素相应脉冲（-hormone抑制激素）。 为CJC-1295在2000年代中期临床研究首次进行的。 肽的目的是治疗内脏脂肪沉积的肥胖艾滋病患者中，作为外源性水平的提高被推定增加脂肪分解（脂肪损失）。 临床研究是对于大多数的研究课题最终取得了成功。 生长激素释放肽，释放出的直觉，这循环并作为一个饥饿激素，在体内与GHRH协同作用，也抑制生长激素抑制素，以让路GHRH脉冲。 研究表明，GHRP-6结合的CJC 1295数模转换器，显著增加GH和生产的释放而不增加催乳激素。 一个GHRP（GH释放肽）的一个例子是海沙瑞林或GHRP-2。 CJC 1295 DAC是一种特别设计的肽和被称为是最好的secretogues的。 该DAC（药物亲和复合物）部通过与血清白蛋白结合增加了半衰期并保护免于降解的CJC-1295的DAC肽。 这是时形成的赖氨酸链接被界定为DACS到一个名为maleimidoproprionic酸（MPA）反应的化学品。

CJC-1295 with DAC

Model NO.: 51753-57-2

Function: Hormones and Regulation of Endocrine Function of Drug, Vitamins and Minerals Deficiency Drug, Nutritional Therapeutics

Certification: GMP, Reach, SGS, FDA

Grade Standard: Medicine Grade

Type: Analysis reagent

State: Solid

Volatile: Not Volatile

Product Name: Cjc1295 Dac

CAS: 51753-57-2

Appearance: White Powder

Purity (HPLC) : 98%

Unit Size: 2mg/ Vial

Usage: Muscle Building

Export Markets: Global

Usage:

CJC-1295 DAC has shown some amazing results as a hormone releasing hormone (GHRH) analog. Not only has CJC-1295 shown the ability to increase hormone and secretion and its benefits, but it has been able to do so in very large amounts. Recent research studies have shown that CJC - 1295 stimulates GH and Secretion, and will keep a steady increase with no increase in prolactin, leading to intense fat loss, and increases protein synthesis.

CJC-1295 DAC is a long acting Hormone Releasing Hormone, which causes the anterior pituitary to release more hormone. GHRH is released in pulses in the body, which alternate with corresponding pulses of somatostatin (-hormone inhibiting-hormone) . Clinical Research was first conducted for CJC-1295 during the MID-2000s. The objective of the peptide was to treat visceral fat deposits in obese AIDS patients, as increased levels of exogenous are presumed to increase lipolysis (fat loss) . The clinical research was ultimately successful for most research subjects. Ghrelin, released from the gut, which circulates and acts as a hunger hormone, has synergistic activity in the body with GHRH and also suppresses somatostatin to make way for the GHRH pulse. Studies shows that combining a GHRP-6 with CJC 1295 DAC, significantly increase the release of GH and production without an increase in prolactin. An example of a GHRP (GH Releasing Peptide) is Hexarelin or GHRP-2. CJC 1295 DAC is a exceptionally designed peptide and is known for being the finest of the secretogues. The DAC (Drug Affinity Complex) portion increases the half-life by binding with serum albumin and protects the CJC-1295 DAC peptide from degradation. This was formed when a lysine link was bounded to DACS to a reactive chemical called maleimidoproprionic acid (MPa) .